Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Neda Rasouli

Concepts (383)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Insulin Resistance
38
2024
1208
4.370
Why?
Diabetes Mellitus, Type 2
41
2025
2531
4.120
Why?
Metformin
20
2025
331
2.950
Why?
Thiazolidinediones
20
2014
137
2.370
Why?
Prediabetic State
10
2024
253
2.310
Why?
Adipose Tissue
24
2016
635
2.060
Why?
Hypoglycemic Agents
34
2025
1291
2.060
Why?
Insulin-Secreting Cells
8
2025
377
1.990
Why?
Sulfonylurea Compounds
6
2025
48
1.430
Why?
Glucagon-Like Peptides
3
2025
58
1.320
Why?
Blood Glucose
26
2025
2186
1.300
Why?
Vitamin D Deficiency
2
2022
186
1.300
Why?
Obesity
24
2019
2992
1.240
Why?
Cholecalciferol
4
2022
60
1.190
Why?
Insulin
23
2025
2409
1.070
Why?
Peripheral Arterial Disease
4
2025
475
1.030
Why?
Cholesterol, HDL
2
2018
203
1.000
Why?
Triglycerides
3
2018
524
0.910
Why?
Fenofibrate
2
2016
28
0.890
Why?
Glucose Tolerance Test
15
2025
366
0.860
Why?
Insulin Glargine
9
2025
84
0.820
Why?
Muscle, Skeletal
11
2016
1724
0.760
Why?
Metabolic Syndrome
3
2018
354
0.710
Why?
Receptors, Ghrelin
1
2020
8
0.690
Why?
Gastroparesis
1
2020
9
0.690
Why?
PPAR gamma
8
2014
182
0.680
Why?
Lipid Metabolism
5
2016
518
0.650
Why?
Middle Aged
53
2025
33479
0.650
Why?
Diabetic Neuropathies
1
2020
94
0.630
Why?
Vitamin D
9
2024
397
0.630
Why?
Glucose
9
2024
1020
0.630
Why?
Adipokines
2
2010
49
0.620
Why?
Hypoxia
2
2016
1112
0.590
Why?
Diabetes Mellitus
6
2020
1040
0.590
Why?
Subcutaneous Fat
5
2014
81
0.580
Why?
Adipocytes
11
2014
222
0.560
Why?
Humans
87
2025
137585
0.530
Why?
Dietary Supplements
7
2022
561
0.510
Why?
Hyperglycemia
5
2016
347
0.510
Why?
Aged
31
2025
23961
0.490
Why?
Vitamins
6
2024
185
0.490
Why?
Remote Consultation
1
2016
54
0.480
Why?
Sitagliptin Phosphate
6
2025
33
0.470
Why?
Liraglutide
6
2025
30
0.470
Why?
Fibrosis
3
2023
552
0.460
Why?
Fatty Acids
2
2016
443
0.460
Why?
Macrophages
10
2014
1547
0.450
Why?
Female
50
2025
73304
0.440
Why?
Inflammation
12
2016
2837
0.440
Why?
Male
49
2025
67762
0.430
Why?
Adult
44
2025
37929
0.420
Why?
C-Peptide
3
2024
163
0.400
Why?
Nuclear Receptor Co-Repressor 1
1
2012
16
0.390
Why?
SUMO-1 Protein
1
2012
21
0.380
Why?
Walking
3
2025
529
0.380
Why?
Glucagon-Like Peptide 1
4
2025
135
0.370
Why?
Double-Blind Method
7
2025
1993
0.370
Why?
Glucose Intolerance
6
2010
146
0.360
Why?
Patient Admission
1
2012
197
0.340
Why?
Histone Deacetylases
1
2012
215
0.340
Why?
Cohort Studies
7
2020
5742
0.330
Why?
Lipids
2
2020
672
0.330
Why?
Receptors, Scavenger
1
2009
23
0.320
Why?
Gene Expression Regulation
6
2015
2607
0.310
Why?
Inpatients
2
2013
500
0.300
Why?
Gene Expression
7
2010
1502
0.280
Why?
Metabolic Diseases
1
2008
108
0.270
Why?
Body Mass Index
11
2021
2389
0.270
Why?
Intermittent Claudication
2
2025
118
0.270
Why?
Adipose Tissue, White
2
2019
41
0.260
Why?
Choristoma
1
2007
21
0.260
Why?
Dietary Fats
1
2008
304
0.250
Why?
Muscles
3
2012
326
0.250
Why?
Incretins
1
2025
22
0.230
Why?
Treatment Outcome
10
2025
10811
0.230
Why?
Gene Expression Regulation, Enzymologic
3
2013
283
0.220
Why?
Young Adult
11
2016
13209
0.210
Why?
RNA, Messenger
11
2015
2833
0.200
Why?
Adiponectin
4
2009
244
0.200
Why?
Dipeptidyl-Peptidase IV Inhibitors
2
2022
47
0.190
Why?
Cystic Fibrosis
1
2012
1114
0.190
Why?
Islets of Langerhans
2
2005
803
0.190
Why?
Insulin, Long-Acting
2
2012
63
0.180
Why?
Ligands
3
2012
664
0.170
Why?
Follow-Up Studies
2
2022
5131
0.170
Why?
Metoclopramide
1
2020
19
0.170
Why?
Gastric Emptying
1
2020
38
0.170
Why?
Glucosides
1
2020
44
0.170
Why?
Cross-Sectional Studies
5
2024
5472
0.160
Why?
Quantitative Trait Loci
2
2012
380
0.160
Why?
China
1
2020
217
0.160
Why?
Benzhydryl Compounds
1
2020
73
0.160
Why?
Enteral Nutrition
2
2012
202
0.160
Why?
Non-alcoholic Fatty Liver Disease
1
2023
279
0.160
Why?
Cardiology
1
2022
274
0.160
Why?
Atherosclerosis
2
2018
415
0.160
Why?
Renal Insufficiency
1
2021
162
0.150
Why?
Coculture Techniques
5
2011
239
0.150
Why?
Insulin, Short-Acting
1
2018
6
0.150
Why?
Linagliptin
1
2018
5
0.150
Why?
Quality of Life
4
2025
2892
0.150
Why?
Adipose Tissue, Brown
1
2019
53
0.150
Why?
Cardiovascular Diseases
3
2022
2111
0.150
Why?
Gene Expression Profiling
4
2015
1774
0.140
Why?
Hyperoxia
1
2019
90
0.140
Why?
Comparative Effectiveness Research
3
2025
152
0.140
Why?
Glomerular Filtration Rate
1
2021
746
0.140
Why?
Incidence
2
2022
2804
0.140
Why?
Cells, Cultured
6
2016
4193
0.130
Why?
Overweight
1
2022
558
0.130
Why?
Stress, Psychological
1
2025
1100
0.130
Why?
Perioperative Care
1
2018
178
0.130
Why?
Surgical Procedures, Operative
1
2018
259
0.120
Why?
Abdominal Fat
2
2006
41
0.120
Why?
Endoplasmic Reticulum
2
2008
265
0.120
Why?
Medical Staff, Hospital
1
2016
83
0.120
Why?
Body Weight
1
2020
985
0.120
Why?
Endocrinology
1
2016
79
0.120
Why?
Arginine
2
2007
271
0.120
Why?
Drug Therapy, Combination
3
2024
1066
0.120
Why?
Thermogenesis
1
2014
44
0.110
Why?
Cell Line
6
2010
2847
0.110
Why?
Scavenger Receptors, Class E
2
2015
2
0.110
Why?
Fish Oils
1
2014
26
0.110
Why?
Oxidation-Reduction
2
2016
1060
0.110
Why?
Area Under Curve
1
2015
314
0.110
Why?
Hospitalization
4
2018
2199
0.110
Why?
Palmitic Acid
3
2011
41
0.110
Why?
Adolescent
7
2016
21513
0.110
Why?
Risk Factors
7
2025
10388
0.110
Why?
Adiposity
2
2010
518
0.100
Why?
Acetyl-CoA Carboxylase
1
2013
33
0.100
Why?
Medically Uninsured
1
2014
130
0.100
Why?
ROC Curve
1
2015
554
0.100
Why?
Biopsy
3
2012
1129
0.100
Why?
Muscle Fibers, Skeletal
2
2011
218
0.100
Why?
Transcriptional Activation
1
2014
378
0.100
Why?
Cardiomyopathies
2
2007
350
0.100
Why?
PPAR alpha
1
2012
58
0.100
Why?
RNA, Small Interfering
2
2012
622
0.100
Why?
CD36 Antigens
2
2009
36
0.100
Why?
Biphasic Insulins
1
2011
3
0.090
Why?
Patient Preference
1
2014
191
0.090
Why?
Seasons
1
2014
547
0.090
Why?
Cytokines
4
2010
2085
0.090
Why?
Insulin Lispro
1
2011
39
0.090
Why?
Antigens, Differentiation, Myelomonocytic
3
2007
61
0.090
Why?
Hypolipidemic Agents
2
2018
91
0.090
Why?
Randomized Controlled Trials as Topic
3
2023
1477
0.090
Why?
Temperature
1
2014
679
0.090
Why?
Insulin Infusion Systems
2
2012
394
0.090
Why?
Continuity of Patient Care
1
2014
284
0.090
Why?
Retrospective Studies
5
2016
15657
0.090
Why?
Patient Care Team
1
2016
631
0.090
Why?
Receptors, Tumor Necrosis Factor
1
2011
164
0.090
Why?
Docosahexaenoic Acids
1
2011
84
0.090
Why?
Molecular Weight
2
2008
335
0.090
Why?
Collagen Type VI
1
2010
6
0.090
Why?
Matrix Metalloproteinase Inhibitors
1
2010
15
0.080
Why?
Lipase
1
2010
69
0.080
Why?
Polymorphism, Single Nucleotide
3
2013
2189
0.080
Why?
Adipogenesis
1
2010
55
0.080
Why?
Lipogenesis
1
2010
61
0.080
Why?
Body Composition
3
2011
684
0.080
Why?
Prognosis
1
2018
4030
0.080
Why?
Bicycling
1
2010
114
0.080
Why?
Scavenger Receptors, Class A
1
2009
12
0.080
Why?
Injections, Subcutaneous
2
2025
157
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
5
2010
976
0.080
Why?
Matrix Metalloproteinase 9
1
2010
132
0.080
Why?
Medicaid
1
2014
435
0.080
Why?
Logistic Models
1
2015
2074
0.080
Why?
Predictive Value of Tests
1
2015
2031
0.080
Why?
Diabetic Nephropathies
1
2013
294
0.080
Why?
Disease Models, Animal
2
2019
4295
0.080
Why?
Myoblasts, Skeletal
1
2009
12
0.080
Why?
MicroRNAs
1
2015
692
0.080
Why?
Heart Failure
1
2022
2236
0.070
Why?
Myositis
1
2009
52
0.070
Why?
Antigens, CD
3
2007
521
0.070
Why?
Chemokine CCL2
2
2007
115
0.070
Why?
Biomarkers
4
2025
4149
0.070
Why?
Fatty Acids, Nonesterified
1
2009
159
0.070
Why?
Stearoyl-CoA Desaturase
1
2008
65
0.070
Why?
Dose-Response Relationship, Drug
4
2020
2057
0.070
Why?
Stress, Physiological
2
2008
443
0.070
Why?
Thrombospondin 1
1
2007
27
0.070
Why?
Infant
2
2020
9465
0.070
Why?
Anti-Inflammatory Agents
1
2011
496
0.070
Why?
Retinol-Binding Proteins
1
2007
18
0.070
Why?
TCF Transcription Factors
1
2007
17
0.070
Why?
Extracellular Matrix
1
2011
528
0.070
Why?
Administration, Oral
2
2020
816
0.070
Why?
Adipocytes, White
2
2019
19
0.070
Why?
Peroxisome Proliferator-Activated Receptors
1
2006
17
0.070
Why?
Down-Regulation
1
2009
657
0.070
Why?
Diacylglycerol O-Acyltransferase
1
2006
5
0.070
Why?
Fatty Acid Synthases
1
2006
24
0.060
Why?
Animals
10
2019
36940
0.060
Why?
Lipoprotein Lipase
1
2006
59
0.060
Why?
Transcriptome
1
2012
971
0.060
Why?
Liver
3
2013
1943
0.060
Why?
Cell Differentiation
2
2011
1991
0.060
Why?
Child, Preschool
1
2020
11074
0.060
Why?
Resistin
1
2005
11
0.060
Why?
Niacin
1
2005
17
0.060
Why?
Genome-Wide Association Study
1
2012
1431
0.060
Why?
Quality Improvement
1
2014
1178
0.060
Why?
Ankle Brachial Index
1
2025
37
0.060
Why?
Fructosamine
1
2004
15
0.060
Why?
Veterans
1
2016
1476
0.060
Why?
Walk Test
1
2025
76
0.060
Why?
Apolipoproteins E
1
2004
83
0.050
Why?
Models, Biological
2
2008
1783
0.050
Why?
Tissue Distribution
1
2005
332
0.050
Why?
Insulin, Regular, Human
1
2024
43
0.050
Why?
Genetic Predisposition to Disease
1
2013
2426
0.050
Why?
Diabetes Complications
1
2006
227
0.050
Why?
Polymorphism, Genetic
1
2007
660
0.050
Why?
Leptin
1
2005
236
0.050
Why?
Phenotype
1
2012
3196
0.050
Why?
Intracellular Signaling Peptides and Proteins
1
2006
455
0.050
Why?
Elastin
2
2014
78
0.050
Why?
Diabetes Mellitus, Type 1
3
2014
3715
0.050
Why?
Anti-Obesity Agents
2
2018
57
0.050
Why?
Exercise Tolerance
1
2025
279
0.050
Why?
Obesity, Morbid
1
2006
264
0.050
Why?
Glucagon-Like Peptide-1 Receptor
1
2022
82
0.050
Why?
Diabetic Ketoacidosis
1
2004
201
0.050
Why?
Arteriosclerosis
1
2002
88
0.050
Why?
Nuclear Proteins
1
2006
712
0.050
Why?
Apoptosis
2
2011
2553
0.050
Why?
Angiotensin Receptor Antagonists
1
2021
92
0.040
Why?
Hypoglycemia
2
2018
445
0.040
Why?
American Heart Association
1
2022
306
0.040
Why?
Recovery of Function
1
2025
653
0.040
Why?
Child
1
2020
21935
0.040
Why?
Liver Cirrhosis
1
2023
316
0.040
Why?
Albuminuria
1
2021
185
0.040
Why?
Coronary Artery Disease
1
2007
698
0.040
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2021
201
0.040
Why?
Multicenter Studies as Topic
1
2021
310
0.040
Why?
Receptors, Cytoplasmic and Nuclear
1
2002
220
0.040
Why?
Calibration
1
2020
146
0.040
Why?
Maximum Tolerated Dose
1
2020
199
0.040
Why?
Creatinine
1
2021
499
0.040
Why?
Sex Factors
1
2025
2071
0.040
Why?
Adipocytes, Brown
1
2019
7
0.040
Why?
Tumor Necrosis Factor-alpha
1
2004
1242
0.040
Why?
Streptozocin
1
2019
21
0.040
Why?
Health Status Indicators
1
2020
171
0.040
Why?
Consensus
1
2022
683
0.040
Why?
Oxidative Stress
1
2006
1317
0.040
Why?
Carbohydrate Metabolism
1
2019
59
0.040
Why?
Mice
7
2013
17787
0.040
Why?
Gynecologic Surgical Procedures
1
2018
63
0.040
Why?
Transcription Factors
2
2008
1719
0.040
Why?
Treatment Failure
1
2019
356
0.040
Why?
Fasting
1
2020
281
0.040
Why?
Digestive System Surgical Procedures
1
2018
106
0.040
Why?
Rats, Wistar
1
2019
455
0.030
Why?
Disease-Free Survival
1
2019
686
0.030
Why?
Diet, High-Fat
1
2019
247
0.030
Why?
Urologic Surgical Procedures
1
2018
120
0.030
Why?
Diabetes Mellitus, Experimental
1
2019
195
0.030
Why?
Transfection
2
2010
945
0.030
Why?
Kaplan-Meier Estimate
1
2019
889
0.030
Why?
Blotting, Western
2
2010
1226
0.030
Why?
Reference Values
2
2008
816
0.030
Why?
G(M2) Activator Protein
1
2015
1
0.030
Why?
Orthopedic Procedures
1
2018
216
0.030
Why?
Myosin Type V
1
2015
9
0.030
Why?
Depression
1
2025
1397
0.030
Why?
ADAM Proteins
1
2015
61
0.030
Why?
3T3 Cells
2
2006
163
0.030
Why?
Aged, 80 and over
2
2018
7635
0.030
Why?
Uncoupling Protein 1
1
2014
16
0.030
Why?
Fibroblasts
2
2011
996
0.030
Why?
Myosin Heavy Chains
1
2015
192
0.030
Why?
Weight Loss
1
2020
787
0.030
Why?
Cluster Analysis
1
2015
499
0.030
Why?
Ion Channels
1
2014
133
0.030
Why?
Time Factors
1
2025
6828
0.030
Why?
Antihypertensive Agents
1
2018
494
0.030
Why?
Mice, Knockout
2
2013
3015
0.030
Why?
Oligonucleotide Array Sequence Analysis
1
2015
767
0.030
Why?
Genome, Human
1
2015
425
0.030
Why?
Mast Cells
1
2014
147
0.030
Why?
Mitochondrial Proteins
1
2014
257
0.020
Why?
Demography
1
2013
291
0.020
Why?
Hypertension
1
2021
1295
0.020
Why?
Organ Specificity
1
2012
305
0.020
Why?
Nerve Tissue Proteins
1
2015
596
0.020
Why?
TWEAK Receptor
1
2011
5
0.020
Why?
Up-Regulation
1
2014
843
0.020
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2011
52
0.020
Why?
Tripartite Motif Proteins
1
2011
41
0.020
Why?
United States
2
2022
14841
0.020
Why?
1-Acylglycerol-3-Phosphate O-Acyltransferase
1
2010
3
0.020
Why?
Capillaries
1
2011
108
0.020
Why?
Genetic Association Studies
1
2013
377
0.020
Why?
Atrophy
1
2011
184
0.020
Why?
Receptors, Adiponectin
1
2010
19
0.020
Why?
Protein Kinase C-alpha
1
2010
37
0.020
Why?
Rats
1
2019
5647
0.020
Why?
Ubiquitin-Protein Ligases
1
2011
175
0.020
Why?
Muscle Proteins
1
2011
231
0.020
Why?
Stromal Cells
1
2010
112
0.020
Why?
Fluorescent Antibody Technique
1
2010
390
0.020
Why?
Th1 Cells
1
2010
143
0.020
Why?
Oligonucleotides
1
2010
148
0.020
Why?
Collagen
1
2011
452
0.020
Why?
Waist-Hip Ratio
1
2008
39
0.020
Why?
Energy Metabolism
1
2014
922
0.020
Why?
Regulatory Factor X Transcription Factors
1
2008
11
0.020
Why?
X-Box Binding Protein 1
1
2008
10
0.020
Why?
Centrifugation, Density Gradient
1
2008
41
0.020
Why?
Mice, Obese
1
2008
66
0.020
Why?
Activating Transcription Factor 6
1
2008
20
0.020
Why?
Pilot Projects
1
2014
1710
0.020
Why?
Transcription Factor CHOP
1
2008
31
0.020
Why?
eIF-2 Kinase
1
2008
31
0.020
Why?
Patient Readmission
1
2014
697
0.020
Why?
Chelating Agents
1
2008
75
0.020
Why?
Sucrose
1
2008
110
0.020
Why?
Endoribonucleases
1
2008
81
0.020
Why?
Retinol-Binding Proteins, Plasma
1
2007
6
0.020
Why?
Cell Fractionation
1
2007
56
0.020
Why?
Oxygen Consumption
1
2010
696
0.020
Why?
Heat-Shock Proteins
1
2008
143
0.020
Why?
Transcription Factor 7-Like 2 Protein
1
2007
26
0.020
Why?
Glucose Transporter Type 4
1
2007
40
0.020
Why?
Patient Discharge
1
2014
897
0.020
Why?
Cell Communication
1
2009
315
0.020
Why?
Nicotinamide Phosphoribosyltransferase
1
2006
7
0.020
Why?
Phosphatidate Phosphatase
1
2006
5
0.020
Why?
Indians, North American
1
2013
643
0.020
Why?
Blotting, Northern
1
2006
201
0.020
Why?
Signal Transduction
2
2011
5079
0.020
Why?
Protein Isoforms
1
2008
404
0.020
Why?
Muscle Cells
1
2006
43
0.020
Why?
Isomerism
1
2006
56
0.020
Why?
Molecular Chaperones
1
2008
195
0.020
Why?
Caspase 9
1
2006
57
0.020
Why?
In Situ Nick-End Labeling
1
2006
124
0.020
Why?
Diet, Carbohydrate-Restricted
1
2006
37
0.020
Why?
Phosphoproteins
1
2008
338
0.020
Why?
Anilides
1
2006
73
0.020
Why?
DNA Primers
1
2006
515
0.020
Why?
Mice, Inbred C57BL
2
2006
5757
0.020
Why?
Longitudinal Studies
1
2013
2844
0.010
Why?
Caspase 3
1
2006
246
0.010
Why?
Cell Culture Techniques
1
2007
363
0.010
Why?
Caspases
1
2006
247
0.010
Why?
Cell Count
1
2005
324
0.010
Why?
In Vitro Techniques
1
2006
1092
0.010
Why?
Genome
1
2006
300
0.010
Why?
Life Style
1
2006
490
0.010
Why?
Genes, Reporter
1
2004
269
0.010
Why?
Colorado
1
2014
4565
0.010
Why?
Homeostasis
1
2007
621
0.010
Why?
RNA
1
2010
921
0.010
Why?
Stem Cells
1
2007
594
0.010
Why?
Enhancer Elements, Genetic
1
2004
190
0.010
Why?
Base Sequence
1
2006
2181
0.010
Why?
Reactive Oxygen Species
1
2006
622
0.010
Why?
Peptide Fragments
1
2006
706
0.010
Why?
Amino Acid Sequence
1
2006
2139
0.010
Why?
Molecular Sequence Data
1
2006
2900
0.010
Why?
Calcium
1
2008
1199
0.010
Why?
Antioxidants
1
2006
584
0.010
Why?
Genotype
1
2007
1916
0.010
Why?
Immunohistochemistry
1
2006
1738
0.010
Why?
Myocardium
1
2006
1002
0.010
Why?
Muscle, Smooth
1
2002
155
0.010
Why?
Morbidity
1
2002
324
0.010
Why?
DNA-Binding Proteins
1
2008
1502
0.010
Why?
Cardiovascular System
1
2002
137
0.010
Why?
Blood Coagulation
1
2002
255
0.010
Why?
Prospective Studies
1
2012
7604
0.010
Why?
Promoter Regions, Genetic
1
2004
1250
0.010
Why?
Mortality
1
2002
362
0.010
Why?
Mitochondria
1
2006
948
0.010
Why?
Rasouli's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)